Berlin, Germany | October 20th - 22nd, 2013

World Health Summit 2011

October 23-26, 2011

Welcome Messages 2011

Angela Merkel, Chancellor of the Federal Republic of Germany

In medicine time can make all the difference between life and death. Obviously in emergen-cies every second counts. In research, however, developing new and effective approaches to combating disease is bound to take some time. But even here it is clear that the faster new scientific findings translate into practical applications, the sooner suffering can be relieved and lives saved. So in research, too, every day counts.

Cooperation is a crucial way of saving valuable time. In Germany we are establishing new research centres for six common diseases that will allow us to pool expertise and speed up the process of translating research results into standard treatments. In the treatment of neglected diseases and the diseases of poverty, too, cooperation is key to achieving rapid progress. Only if researchers, policy-makers, business and civil society work together at international level can we expect solutions that really work.

Cooperation needs mutual trust and understanding. I am therefore delighted that the World Health Summit in Berlin has proved to be an ideal venue for international dialogue in this field. The motto of this year’s conference, “today’s evidence science – tomorrow’s agenda”, high¬lights the seminal role of research in achieving medical advances. It reminds us, too, that shared insights and responsibility must be followed by prompt action.

I wish the World Health Summit 2011 participants and organizers a very productive confer-ence and a host of stimulating discussions and encounters.

Angela Merkel
Chancellor of the Federal Republic of Germany

Nicolas Sarkozy, President of the French Republic

Health is the major topic of the 21st century. The increase of chronic diseases in every part of the world, together with changing demographics, imposes tough challenges on our health systems. The shift to a more personalized medicine brings along great opportunities but also sincere questions of feasibility which we need to solve. This requires true collaboration and close links between governments, researchers and industry, between public and private sectors. Financial constraints force us to increase efficiency and reduce costs but not the quality of health care. This requires less bureaucracy for more action.

Eleven years ago, the world committed itself to the Millennium Developmental Goals: reduce extreme poverty, increase education, decrease child mortality, improve maternal health, and reduce infectious diseases. We still have a considerable way ahead of us. The financial crisis has left its severe marks in rich countries while it costs lives in the poorest ones. We need innovative financing models and new governance structures to sustain the financial engagements of the rich countries for the poor. Our structures have to adapt to the health challenges of the 21st century.

The World Health Summit being held at the Charité in Berlin has become the foremost global meeting of its kind to convene leaders from academia, economy, industry, governments, international organizations and civil society around the pressing health issues of our time. It also contributes to promote the work fulfilled by the M8 Alliance which brings together eight major faculties of medicine throughout the world.

I wish all the best for the 3rd edition of the World Health Summit.

Nicolas Sarkozy
President of the French Republic



Today’s Science

We are living in an extraordinary period of history. Never before has the world experienced such progress in research and technology development, not only to fight diseases but also to prevent them, improving the quality of life worldwide. At the same time, our world is experiencing tough challenges: the rapid increase of non-communicable diseases and mental illness in addition to the still raging epidemics of HIV, TB and malaria strongly influence today’s health care and research agendas. Nearly 8 million children and pregnant women die every year as a consequence of preventable causes. The health effects of climate change are already being felt as the warming of the planet directly influences the distribution of food and water, but also of vector-borne diseases. What are effective strategies to adapt our research agendas to these increasing challenges? How can different stakeholder groups improve collaboration on an international scale to speed up and develop joint solutions?

· Response to Global Emerging Infectious Outbreaks
· No Health without Mental Health
· Adolescent Health - Its promise and potential


Research and Innovation

Medical advances arise from collaboration and mutual understanding between academia and health care providers, politicians and the private sector. The academic community is aware of its responsibility to deliver results based on a strong collaborative approach to improve global health. This comprises basic and preclinical research and the development of new therapies, but also increasingly the delivery of health services. The burning medical questions and health issues of our time need scientific answers without delay. How can we reorganize the academic system to increase translational efficiency between academic medicine, industry and others who are responsible for health care delivery? Effective incentives are needed for the development of “vulnerable” drug classes, e.g. antibiotics and of medical innovations for diseases of global health importance. What mechanisms do we need and how can the innovation process be accelerated? How can we realize adequate adaption of therapeutics to fit local conditions? What mechanisms and collaboration models do we need to tackle the health threat caused by counterfeit drugs?

· Bridging Health Gaps with Vaccines
· Innovation for Diseases of Global Health Importance
· Product Development for Neglected Patients


Strengthening Health Systems

Strong health systems are the basis of all development. Governments around the world are struggling with the challenges of providing good-quality healthcare under conditions of increasing financial constraints. Evidence on which to base sound rational decisions is in short supply. Critical shortages, an inadequate skill-mix and an uneven geographical distribution of the health workforce pose major barriers to achieving the health-related Millennium Development Goals (MDGs). The essential prerequisites of good health systems are a solid basis of public health education and adequate training of the health work-force. Information and communication technologies offer exciting innovative tools for many healthcare sectors. In addition, society and the media have to take much greater responsibility for the promotion of health and the prevention of diseases.

· Global Health Workforce Crisis
· The Future of Medical Education in a Globalized World
· Promoting Health, Preventing NCD


Tomorrow’s Agenda

Good health governance has always been of the utmost importance. However, evidence in this field is still weak. No country has yet discovered an ideal health-service model. Therefore the links between evidence and policy on all levels (national and international) need to be strengthened. How must innovative models of effective health collaboration and surveillance systems be shaped to tackle global challenges such as the increase of chronic diseases or the health consequences of global warming and degraded environment and urbanization? How can we control the various structural, socio-cultural and economic determinants of health? These are some of the important topics on tomorrow´s agenda.

· Evidence to Policy Linkages
· Strengthening National Governance of Research for Health
· Ensuring Public Health in Times of Climate Change


Speakers 2011

Karl Addicks
Physician, Former Member of the German Bundestag, Germany

Alvar Agusti
Director, University of Barcelona, Spain

Dora Nkem Akunyili
General Director, National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria

Paul Aliu
Global Program Team Director, Novartis, Switzerland

Ala Alwan
General Director, World Health Organization, Switzerland

Boris Azais
Director Policy Affairs, MSD, France

Brendan Barnes
Director, Health Policy and Corporate Responsibility, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium

Marie Bashir
Governor of New South Wales, Australia

Jorge Baxter
Director of Global Education and Outreach, Sesame Foundation, USA

Delphine Bazalgette
Country Representative, PlaNet Finance Deutschland e.V., Germany

Shalini Bharat
Chairperson of the Centre for Health and Social Sciences, Tata Institute of Social Sciences, School of Health Systems Studies, India

Mark Blecher
National Treasury, South Africa

Francois Bompart
Vice-President, Deputy Head and Medical Director Access to Medicines, Sanofi, France

Edward Bouwer
Professor, Johns Hopkins Bloomberg School of Public Health, USA

Nigel Bruce
Reader in Public Health, World Health Organization and Liverpool School of Tropical Medicine, UK

Reinhard Burger
President, Robert-Koch-Institute, Germany

Giovanni Cerri
Secretary of Health, Department of Health, State of Sao Paulo, Brazil

James Chau
TV Presenter, CCTV News, China

Rethy Chhem
Director, Section of Nuclear Medicine, Division of Human Health, International Atomic Energy Agency, Austria

Mickey Chopra
Chief of Health and Associate Director of Programmes, UNICEF, USA

John Clark
Pfizer GmbH, Germany

Pamela Collins
Director, Office for Research on Disparities and Global Mental Health, National Institute of Mental Health, USA

Nigel Crisp
Former Head of The Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK

David de Kretser
Monash University, Faculty of Medicine, Nursing and Health Sciences, Australia

Nicoletta Dentico
Co-Director, Health Innovation for People (HIP), Australia

Philippe Douste-Blazy
Director, UNITAID, France

Mark Dybul
Co-Director, Global Health Law Program, Georgetown University, USA

Karl Max Einhäupl
CEO, Charité Universitätsmedizin Berlin, Germany

Christopher J. Elias
President and CEO, PATH, USA

David B. Evans
Director, World Health Organization, Switzerland

Antoine Flahault
Director and President, EHESP and ASPHER, France

Jean-Marc Fleury
Project Director and WFSJ Executive Director, World Federation of Science Journalists, Canada

Bronwyn Fredericks
Senior Research Fellow, Monash University, Australia

Howard Frumkin
Dean of the School of Public Health, University of Washington, USA

Shunichi Fukuhara
Director, Department of Epidemiology and Healthcare Research, Kyoto University School of Medicine and Public Health, Japan

Detlev Ganten
Co-President World Health Summit, Charité Universitätsmedizin Berlin, Germany

Patricia Garcia
Director of the Unit of Epidemiology, STI and HIV, Universidad Peruana Cayetano Heredia, Peru

Stefan German
Director for Partnerships and Research, World Vision International, Switzerland

Gerd Gigerenzer
Director, Harding Center for Risk Competence, Max-Planck-Institute, Germany

Jean-François Girard
President, Sorbonne Paris Cité, France

Marius Greuèl
Director, Pflegewerk Berlin, Germany

Joanna Groves
CEO, International Alliance of Patients' Organizations, UK

Annette Grüters-Kieslich
Dean, Charité Universitätsmedizin Berlin, Germany

Debbie Guha-Sapir
Director, Université Catholique de Louvain, WHO Collaborating Centre for Research on the Epidemiology of Disasters (CRED), Belgium

Sergio Guillèn
CEO, TSB Technologies for Health and Well-being, Spain

Nyaradzahi Gumbonzvanda
General Secretary, World Young Women's Christian Association, Switzerland

Thuy Huong Ha
Director Pharmaceutical Management Unit, Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

Mareike Haase
Global Health Advocacy Officer, terre des hommes Deutschland e.V./ Action for Global Health, Germany

Andrew Haines
Director, London School of Hygiene and Tropical Medicine, UK

Victoria Hale
CEO, Medicines360, USA

Peter Hammann
R&D TSU Infectious Disease, Head External Opportunities and Innovation, Sanofi, Germany

Sheikh Hasina
Prime Minister, Bangladesh Government, Bangladesh

Robert Hecht
Principal and Managing Director, Results for Development Institute, UK

Dagfinn Høybråten
Chair of the Board, GAVI Alliance, Switzerland

Frika Chia Iskandar
Coordinator, Woman Working Group, Asia Pacific Network of People Living with HIV and AIDS (APN+), Thailand

Zsuzsanna Jakab
Director European Regional Office, World Health Organization, Denmark

W. Philip T. James
Hon. Professor of Nutrition, London School of Hygiene and Tropical Medicine, UK

Dean Jamison
University of Washington, USA

Jean Jannin
Coordinator, World Health Organization, Switzerland

Klaus Juffernbruch
Director, Connected Health, Cisco Systems GmbH, Germany

Jorge Kalil
Director, Instituto do Coracao AC, FMUSP, Brazil

Unni Karunakara
President of the International Council, Doctors Without Borders, Switzerland

Elly Katabira
Associate Professor of Medicine, Makerere Medical School, Uganda

Stefan Kaufmann
Director, Max-Planck Institute for Infection Biology, Germany

Michel Kazatchkine
Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

Ilona Kickbusch
Director, Global Health Programme, The Graduate Institute, Geneva, and Chair, Global Health Europe, Switzerland

Marie-Paule Kieny
Assistant Director General, World Health Organization, Switzerland

Michael J. Klag
Dean, Johns Hopkins Bloomberg School of Public Health, USA

Sabine Kleinert
Senior Executive Editor, The Lancet, UK

Friedrich Köhler
Director, Center for Cardiovascular Telemedicine, Charité - Universitätsmedizin Berlin, Germany

Eduardo Krieger
Brazilian Academy of Sciences and FMUSP, Brazil

Rudo Kwaramba
National Director, World Vision, Uganda

Jostacio Lapitan
Technical Officer, World Health Organization, Japan

Melanie Leitner
Chief Operating Officer, Chief Scientific Officer, Prize4Life, USA

Catherine Leport
Mission Pandemic Infectuous and Tropical Diseases, University Paris Diderot, France

James Love
Director, Knowledge Ecology International, USA

Anthony McMichael
Professor of Population Health, The Australian National University, Australia

Bettina Menne
Programme Manager Climate Change, Green Health Services and Sustainable Development, World Health Organization, Italy

Angela Merianos
Project Lead, Risk Assessment and Decision Support, World Health Organization, Switzerland

Philippe Meyer
Board Member, Genshagen Foundation, France

Suzie Miller
Monash University, Australia

Christina Mitchell
Dean, Monash University, Faculty of Medicine, Nursing and Health Sciences, Australia

Jürgen Mlynek
President, Helmholtz Association, Germany

Matshidiso Moeti
Assistant Regional Director, WHO, Regional Office for Africa (WHO / AFRO), Botswana

Themba Moeti
Managing Director, African Comprehensive HIV/AIDS Partnerships (ACHAP), Botswana

Joachim Müller-Jung
Head of the Department of Nature and Science, Frankfurter Allgemeine Zeitung, Germany

Maria Neira
Director, World Health Organization, Switzerland

Emmanuel Yuniwo Nfor
Senior Advisor, Supply Chain Management and Strategic Support, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

Alexander Nies
Head, Department IG II Environment and Health, Chemical Safety, Federal Ministry for the Environment, Nature Conservation and Nuclear Safety, Germany

Violet Otindo
Media for Environment, Science, Health and Agriculture (MESHA), Kenya

Tikki Pang
Director, World Health Organization, Switzerland

Bernard Pécoul
Executive Director, Drugs for Neglected Diseases Initiative (DNDI), Switzerland

Roger Peng
Associate Professor, Johns Hopkins Bloomberg School of Public Health, USA

Christian Pfleiderer
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, Germany

Martin Prince
Professor of Epidemiological Psychiatry, King's College London, UK

Hugh Pullen
Associate Director External Trade and Product Integrity, S.A. Eli Lilly Benelux N.V., Belgium

Atif Rahman
Professor of Child Psychiatry, University of Liverpool, UK

Rino Rappuoli
Global Head of Vaccines Research, Novartis, Italy

Hoda Rashad
Director and Research Professor, Social Research Center, American University in Cairo, Egypt

Scott Ratzan
Vice President, Global Health, Government Affairs and Policy, Johnson&Johnson, USA

Olivier Raynaud
Senior Director, World Economic Forum, Switzerland

Ulrika Rehnstrom
United Nations Population Fund UNFPA, Sudan

Hermann Requardt
Sector CEO Healthcare, Siemens, Germany

Heinz Riederer
Executive Board, Sanofi, Germany

Ernst Rietschel
Steering Committee Representative, acatech - National Academy of Science and Engineering, Germany

Matthias Rompel
Director, Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ), Germany

Karin Roth
Member of the German Parliament, Germany

Nabil Safrany
European Commission, DG SANCO, Belgium

Dirk Sander
Consultant, Department Structural Prevention, Deutsche AIDS-Hilfe e.V., Germany

Shekhar Saxena
Director, World Health Organization, Mental Health and Substance Abuse Department, Switzerland

Hans-Joachim Schellnhuber
Director, Potsdam Institute for Climate Impact Research (PIK), Germany

Bernhard Schwartländer
Director, Evidence, Strategy and Results Department, UNAIDS, Switzerland

Robert Sebbag
Vice President Access to Medicines, Sanofi, France

Soraya Seedat
Professor of Psychiatry, Stellenbosch University, South Africa

Marylou Selo
President, Werner A. Selo Foundation, New York, USA

Michel Setbon
Ecole des Hautes Etudes en Santé Publique (EHESP), France

Martin Seychell
Deputy Director General for Consumers and Health, European Commission, Belgium

Mubashar Sheikh
Executive Director, Global Health Workforce Alliance, World Health Organization, Switzerland

Olive Shisana
CEO, South African Human Sciences Research Council, South Africa

Jae Hoon Song
Director, Samsung International Hospital Project, Korea

Agnes Soucat
Director, African Development Bank, Tunisia

Marc Sprenger
Director, European Centre of Disease Prevention and Control (ECDC), Sweden

Bruno Strigini
President of Europe/Canada, MSD, United Kingdom

Michael Strübin
Programme Manager, Europe, Continua Health Alliance, Belgium

Ellen t'Hoen
Executive Director, Medicines Patent Pool, Switzerland

Keizo Takemi
Senior Fellow, Global Health and Human Security, Japan Center for International Exchange, Japan

Yot Teerawatananon
Director of the Health Intervention and Technology Assessment Program, Ministry of Health, Thailand

H. E. Peter Tesch
Ambassador of Australia in Berlin, Germany

James Tielsch
Professor, Johns Hopkins Bloomberg School of Public Health, USA

Tido von Schön-Angerer
Director, Doctors Without Borders, Switzerland

Jane Waterman
CEO, International AIDS Vaccine Initiative (IAVI), The Netherlands

Günther Wess
CEO and President, Helmholtz Association, Germany

Annette Widmann-Mauz
State Secretary, Ministry of Health, Germany

Ulf Wiinberg
President and CEO, H. Lundbeck A/S, Denmark

John Wong
Dean at the Yong Loo School of Medicine, National University of Singapore, Singapore

Klaus Wowereit
Governing Mayor of Berlin, Germany

Shunichi Yamashita
Vice President, Fukushima Medical University, Japan

Anette-Gabrielle Ziegler
Director, Insitute of Diabetes Research, Helmholtz Association, Germany

World Health Summit 2011 in the Media

Lancet Editorial

November 5th, 2011

Berlin has now secured its place on the global health calendar, and not a moment too soon in a world where Anglo-American hegemony stifles diversity in international health debates. The World Health Summit is in its third year. Held at the Charite hospital, where the towering presence of Rudolf Virchow can still be felt, last week’s meeting succeeded in being more cosmopolitan than ever before.

Author: Richard Horten

Download PDF

Deutsches Ärzteblatt: Lichtblicke im Gesundheitswesen

November 4th, 2011

Bangladeschs Gesundheitsminister, Prof. Dr. med. Ruhal Haque, spricht auf dem Weltgesundheitsgipfel mit Dr. med. Vera Zylka-Menhorn vom Deutschen Ärzteblatt über die größten gesundheitspolitischen Herausforderungen in seinem Land.

Die Auswirkungen des Klimawandels, Infektionskrankheiten und Überbevölkerung bedrohen die Gesundheit der bangladeschischen Bevölkerung. Die Einrichtung von 120 000 stationären und 20 000 mobilen Impfstationen eröffnet Lichtblicke im Gesundheitswesen von einem der ärmsten Länder der Welt.

Author: Dr. Vera Zylka-Menhorn

Deutsches Ärzteblatt: Journalisten sind mächtige Promotoren für die Gesundheit

November 4th, 2011

Welche Rolle spielen die Medien bei der Kommunikation von Gesundheitsthemen? Diese Frage stand im Mittelpunkt der Diskussionsrunde „The Crucial Role of Media in Health Promotion“, die im Rahmen des World Health Summit stattfand. Auf Einladung des Deutschen Ärzteblatts diskutierten Prof. Dr. phil. Gigerenzer vom Max-Planck-Institut für Bildungsforschung (Berlin), Jorge Baxter, Direktor der Abteilung Globale Erziehung und Öffentlichkeitsarbeit des Sesame Workshops (New York), Violet Otindo, preisgekrönte Wissenschaftsautorin Kenia (Nairobi) und Prof. Jean-Marc Fleury, Direktor des Weltverbands der Wissenschaftsjournalisten.

Author: Martina Merten, Dr. Marc Meissner


Ärzte Zeitung: Global Health Deutschland ist kopflos

November 2nd, 2011

Auf dem World Health Summit 2011 wurde das Fehlen einer gemeinsamen europäischen Strategie für eine globale Gesundheitspolitik thematisiert. Insbesondere in Deutschland als größter europäischer Staat ist, laut Helmut Brand, Leiter des Department of International Health an der Maastricht Universität, die ministerielle Zuständigkeit und interministerielle Kooperation ungeklärt.

Author: Eugenie Wulfert


Medizingipfel: Mehr Impfungen und neue Antibiotika gefordert

November 1st, 2011

Neue Impfstoffe, bessere Antibiotika und präventive Gesundheitsprogramme – dies sind drei der Bausteine, mit denen der steigenden Verbreitung von chronischen Leiden und dem Auftreten von zunehmend resistenten Problemkeimen begegnet werden soll. So könnten sich die Herausforderungen meistern lassen, vor denen die Gesundheitsysteme weltweit stehen, glauben die Konferenzteilnehmer des „World Health Summit 2011“, der Ende Oktober in Berlin stattgefunden hat.,did=136852.html


Ärzte Zeitung: Oft keine preiswerten Arzneien für Schwellenländer

November 1st, 2011

Laut dem Direktor der Hilfsorganisation Ärzte ohne Grenzen, Tido von Schoen-Angerer, stellen viele Pharmaunternehmen weniger ermäßigte Medikamente für Länder mit mittlerem Einkommen bereit. Auf dem World Health Summit in Berlin erläuterte von Schoen-Angerer die negativen Folgen von diesem Trend für die Nachhaltigkeit nationaler HIV/AIDS-Behandlungsprogramme.

Author: n.n.


Gerechte Gesundheit: Weltgesundheitsgipfel 2011: Gesundheit muss auf die Agenda

October 28th, 2011

Am Ende des World Health Summit 2011 wurde die Notwendigkeit einer sektorenübergreifende Zusammenarbeit für Bewältigung der drängenden globalen Gesundheitsherausforderungen betont. Die immense Zunahme chronischer Krankheiten und die Gesundheitsfolgen des Klimawandels können nach Ansicht der Teilnehmer und Initiatoren nur durch intensive Zusammenarbeit bekämpft werden.

Author: n.n.


Berliner Zeitung: Ideen für eine bessere Welt –
Gesundheitsgipfel appelliert an die Kreativität

October 27th, 2011

Am 26. Oktober 2011 ging der dritte World Health Summit in Berlin zu Ende. Die 1400 Teilnehmer aus über 70 Ländern waren sich einig: Der Weltgesundheitsgipfel ist ein einmaliges intersektorales Forum für den Austausch von Informationen und Ideen.

Author: Lilo Berg

Download PDF

Frankfurter Rundschau: Damit es vielen besser geht

October 27th, 2011

Die Prävention und Bekämpfung von chronischen Erkrankungen war ein zentrales Thema auf dem diesjährigen Weltgesundheitsgipfel in Berlin. Experten aus aller Welt diskutierten die Eindämmung des Tabakkonsums in den Entwicklungsländern, kreative Finanzierungskonzepte  und die effizientere Umsetzung von wissenschaftlichen Erkenntnissen.

Author: Lilo Berg

Download PDF

Märkische Allgemeine: SOFTWARE: Silicon Sanssouci bringt Krebstherapie voran
SAP-Innovationszentrum entwickelt erste neue Anwendungen / Glänzender Gewin

October 27th, 2011

Der Softwareriese SAP stellte auf dem World Health Summit die ersten Erfolge seines neu gegründeten SAP Innovation Center Potsdam vor. In Zusammenarbeit mit der Charité – Universitätsmedizin Berlin und dem Potsdamer Hasso-Plattner-Institut wurde eine Software entwickelt, die der besseren Behandlung von Krebspatienten dienen soll. Der „Hana Oncolyzer“ soll die Krebsforschung voranbringen.

Author: Gerald Dietz

The Tokyo Times: A more depressed Japan needs mental health reform

October 26th, 2011

Japan is experiencing an increased mental health rate after the natural disaster which caused the nuclear crises in March 2011. Shekhar Saxena, a top official at the mental health department of the World Health Organisation, explained at this year’s World Health Summit that since then, the occurrence of depression and other mental diseases has doubled. 

Author: n.n.


Handelsblatt: Unser Leben macht uns krank

October 26th, 2011

Gegenüber dem Handelsblatt erläutert Dr. Mazda Adli, Geschäftsführer des World Health Summit, die Ursachen für die globale Zunahme von chronischen sowie psychischen Erkrankungen. Neben den veränderten Arbeitsbedingungen in den Industrienationen und der zunehmenden Urbaniserung stellen auch der demographische Wandel und die Adaption an den westlichen Lebensstil in den Entwicklungsländern große Herausforderungen für die Gesundheitssysteme dar.

Author: Dr. Mazda Adli



The Daily Star: Make Medicare Affordable

October 24th, 2011

On her visit of the World Health Summit in Berlin, Bangladesh’s Prime Minister, Sheikh Hasina, called for the development of global and regional partnership in health technology to ensure greater access to medicine at affordable prices.

Author: n.n.


Gerechte Gesundheit: Internationaler Weltgesundheitsgipfel tagt in Berlin

October 24th, 2011

„Today’s Science – Tomorrow’s Agenda” lautet das Motto des diesjährigen Weltgesundheitsgipfels. „Unsere Agenda soll ein Weckruf sein“, sagt Prof. Detlev Ganten, Präsident des Gipfels. „Die Wissenschaft macht schnelle Fortschritte, doch die Implementierung und praktische Anwendung dieser Errungenschaften ist bisher unzureichend und enttäuschend.“

Author: n.n.


Ärzte Zeitung: Entwicklungsländer profitieren nicht vom Fortschritt

October 24th, 2011

Die Menschen in den Entwicklungsländern profitieren kaum vom medizinischen Fortschritt. Auf dem World Health Summit 2011 beschäftigen sich 1200 Teilnehmer aus 80 Nationen mit der Frage, wie der wissenschaftliche Fortschritt effizienter auch die Menschen in den ärmsten Regionen der Welt erreichen kann.

Author: n.n.


Der Tagesspiegel: Gesundheit für alle

October 24th, 2011

Bereits zum dritten Mal findet der World Health Summit in Berlin statt. Der Gipfel, auf dem sich 1200 Teilnehmer aus 80 Ländern zusammenfinden, ist zu einer festen Größe im Kongressleben der Hauptstadt geworden. Prof. Detlev Ganten, Initiator und Präsident des Gipfels, möchte ihn als „Weckruf“ verstanden wissen, der auf die unzulängliche praktische Umsetzung wissenschaftlicher Fortschritte aufmerksam macht.

Author: Adelheid Müller-Lissner


Berliner Morgenpost: 1200 Teilnehmer treffen sich zum World Health Summit

October 22nd, 2011

Wie können die Errungenschaften der medizinischen Forschung am effizientesten die Menschen rund um den Erdball erreichen? –Diese Frage steht im Mittelpunkt des diesjährigen World Health Summit in Berlin. Auch 2011 werden wieder führende Persönlichkeiten und Entscheidungsträger aus Wissenschaft, Medizin, Gesundheitswesen und Zivilwirtschaft sowie aus der Politik erwartet.

Author: Britta Klar



Steve Wesselingh: the wizard of Oz

October 22nd, 2011

Thinking of a title for a profi le can be a tricky business, but Steve Wesselingh, who hails from Australia, brought out the worst in The Lancet. “Steve Wesselingh: g’day M8” was briefly considered (he is Co-President with Detlev Ganten of both the M8 Alliance of Academic Health Centres and Medical Universities and the World Health Summit 2011). “Steve Wesselingh: the Aussie rules” was also in contention (he played Australian rules football, and has recently taken up the role of Executive Director at Australia’s most ambitious medical research enterprise, the South Australian Health and

Medical Research Institute). But the wizard of Oz won out because it aff ords a chance to quote that wisest of wizards, Albus Dumbledore.

Author: David Holmes


The Lancet: Science to policy: M8 Alliance invites policy makers to step in

October 22nd, 2011

A year ago, we introduced the M8 Alliance and called for academic medicine to take more responsibility for global health. The M8 Alliance connects leading medical universities and national academies worldwide to create a network that actively seeks dialogue with governmental representatives, policy makers, non-governmental organisations, civil society, and health-related industry on specific global health challenges.

Authors: Mazda Adli, Sabine Kleinert, Mathias Bonk, Steve Wesselingh, Detlev Ganten


Deutsche Ärzteblatt

October 21st, 2011

Since the World Health Summit 2009 the „Deutsche Ärzteblatt“ (Journal of the German Medical Association) publishes a special edition in cooperation with the conference. Find the essentials of the Journal here:

Masterplan für Äthiopien - Moderne Psychiatrie im Einklang mit traditionellen Heilmethoden
Download (PDF, 1,3MB)

Forschung in Afrika - Zaghafter Aufschwung
Download (PDF, 1,3MB)

Global Health in der medizinischen Ausbildung - Die Universitäten sind in der Pflicht
Download (PDF, 4,3MB)

Produktentwicklungspartnerschaften - Innovatives Organisationsmodell zur Förderung globaler Gesundheit
Download (PDF, 0,9MB)

Psychische Erkrankungen - Eine weltweite „Epidemie“
Download (PDF, 5,3MB)

„CAPACITY BUILDING“ - Eine Aufgabe der akademischen Welt
Download (PDF, 1,2MB)



Projekt Zukunft: Studiogast Detlev Ganten, Präsident World Health Summit (TV)

October 17th, 2011

Prof. Detlev Ganten ist Pharmakologe und hat die Evolution von Krankheiten untersucht. Mit Projekt Zukunft spricht er über den weltweiten Anstieg von Allergien und die Themen des diesjährigen Weltgesundheitsgipfels.



Deutsche Welle-TV, Projekt Zukunft

October 17th, 2011

Vom 23.-26. Oktober 2011 findet zum dritten Mal der Weltgesundheitsgipfel in Berlin statt. Ein Schwerpunktthema: "Gesundheit in Zeiten des Klimawandels" - das betrifft auch Allergien, die weltweit zunehmen. Der Pharmakologe Prof. Detlev Ganten spricht mit Projekt Zukunft über den weltweiten Anstieg der Allergien sowie die Themen des kommenden Gipfels in Berlin.



Atlantische Initiative: Global Must Reads – Globale Gesundheit

October, 2011

Newsletter der Atlantischen Initiative: Strategische Studien und Analysen der Internationalen Politik und Globalisierung

Autoren: Dr. Johannes Bohnen, Jan-Friedrich Kallmorgen

Download PDF

The Future of Healthcare - Where are we heading to ?
August 24th, 2011

Health has humanity’s most precious and most universal value, but it is also our most sensitive resource. Globalization has greatly contributed to economic growth, but at the same time our world has become more vulnerable to economic downturn. As health systems across the world expand their reach and services, the costs of healthcare are expanding enormously. Healthcare and research systems have to respond to these challenges. Academia, governments, industry and the civil society must develop joint solutions with a global and multi-disciplinary approach.




Press Report WHS 2011

Press Report WHS 2011
(PDF, 14,9 MB)

Please click here.

Book of Proceedings 2010

Book of Proceedings 2010
(PDF, 5,4 MB)

Please click here.

Final Program 2011

Final Program
World Health Summit 2011
(PDF, 9,3 MB)

Please click here.

3rd Announcement 2011

3rd Announcement
World Health Summit 2011
(PDF, 9,7 MB)

Please click here.

2nd Announcement 2011

Second Announcement
World Health Summit 2011
(PDF, 9,9 MB)

Please click here.


Program Planner

Find out all about
speakers and sessions >>>

WHS Yearbook 2016

M8 Declaration

Picture Gallery

Video Recordings


To get the latest updates, please sign up here >>>

Meet the Team

The Berlin Office >>>

Twitter  Facebook  LinkedIn  Youtube